Although DBC1 was first recognized as a tumor suppressor because it is deleted in breast cancer [12] and principally inhibits SIRT1 [10], recently there has been increasing evidence that DBC1 has an important role in the progression of human cancers via various cellular pathways [13], [15]. This evidence concerns the gene CCAR2 and neoplasm.